Amundi’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,065
| Closed | -$34.9K | – | 2002 |
|
|
2025
Q1 | $34.9K | Sell |
5,065
-43,730
| -90% | -$301K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $587K | Sell |
48,795
-11,987
| -20% | -$144K | ﹤0.01% | 1533 |
|
|
2024
Q3 | $1.09M | Buy |
60,782
+20,508
| +51% | +$367K | ﹤0.01% | 1274 |
|
|
2024
Q2 | $924K | Sell |
40,274
-17,054
| -30% | -$391K | ﹤0.01% | 1220 |
|
|
2024
Q1 | $1.22M | Buy |
57,328
+820
| +1% | +$17.5K | ﹤0.01% | 1249 |
|
|
2023
Q4 | $1.66M | Sell |
56,508
-9,466
| -14% | -$277K | ﹤0.01% | 1242 |
|
|
2023
Q3 | $1.97M | Buy |
65,974
+20,897
| +46% | +$623K | ﹤0.01% | 1180 |
|
|
2023
Q2 | $1.84M | Buy |
45,077
+27,294
| +153% | +$1.11M | ﹤0.01% | 1175 |
|
|
2023
Q1 | $636K | Buy |
17,783
+847
| +5% | +$30.3K | ﹤0.01% | 1328 |
|
|
2022
Q4 | $635K | Sell |
16,936
-6,490
| -28% | -$243K | ﹤0.01% | 1362 |
|
|
2022
Q3 | $1.43M | Buy |
23,426
+12,819
| +121% | +$781K | ﹤0.01% | 1192 |
|
|
2022
Q2 | $677K | Buy |
10,607
+4,720
| +80% | +$301K | ﹤0.01% | 1229 |
|
|
2022
Q1 | $388K | Buy |
5,887
+3,750
| +175% | +$247K | ﹤0.01% | 1319 |
|
|
2021
Q4 | $191K | Buy |
2,137
+291
| +16% | +$26K | ﹤0.01% | 1480 |
|
|
2021
Q3 | $248K | Buy |
+1,846
| New | +$248K | ﹤0.01% | 1398 |
|